Common blood-thinning drugs reduce risk of hospital deaths from Covid: Study


Dexamethasone was a success that reduced the risk of death for patients on ventilators by a third.

Blood-thinning drugs reduced the risk of death from Covid-19 in a new study, pointing to another promising tool that doctors use to search their medicine cabinets for treatments to help ease the pandemic.

About 14% of patients who were given anticoagulants within 24 hours of hospitalization died from the coronavirus, compared with 19% of those who did not. This is according to a study published in the British Medical Journal on Friday. The patients were treated with heparin, an injected blood thinner made by generic drug companies such as Teva Pharmaceutical Industries Ltd. was sold.

Scientists have looked for available, inexpensive drugs to help seriously ill Covid-19 patients, as more elaborate treatments disappoint. One of the greatest successes to date has been dexamethasone, a steroid that has been shown to reduce the risk of death for patients on ventilators by a third.

Blood thinner results are based on data from more than 4,000 patients, mostly men, from the US Department of Veterans Affairs. You were hospitalized with Covid-19 between March 1 and July 31. According to the study, the patients who received anticoagulants did not have an increased risk of bleeding.


The study is observational, which means the results need to be confirmed by clinical trials and some are ongoing, the scientists said. The drugs could show a result as blood clots that develop in large veins and arteries could be responsible for Covid deaths, according to research.

(Except for the headline, this story was not edited by GossipMantri staff and published from a syndicated feed.)


Please enter your comment!
Please enter your name here